Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from ADA 2017.
Julia Greenstein, Ph. D. is the JDRF Vice President of Discovery Research, which includes early-stage programs across the JDRF portfolio. Dr. Greenstein has more than 20 years of experience in the corporate biotechnology arena, holding leadership positions that have helped accelerate discoveries to market. Before joining JDRF as a consultant in 2005, Dr. Greenstein was the chief executive officer and president of Immerge BioTherapeutics, a Novartis and BioTransplant joint venture focused on the development of pig xenotransplantation for clinical practice. Prior to this position, she held the roles of chief scientific officer and senior vice president of research at BioTransplant and vice president of discovery research at ImmuLogic Pharmaceutical Corp.
Featured videos include:
Pt.2: Diabetes Prevention
Pt.4: Final Thoughts
or view the complete interview here: Complete Interview.